Funded Startups in Wageningen
Disclosed round sizes in Wageningen cluster heavily below the top of the list: the largest disclosed amount is Micreos ($25M, 2022-10-25), and every other…
Disclosed round sizes in Wageningen cluster heavily below the top of the list: the largest disclosed amount is Micreos ($25M, 2022-10-25), and every other disclosed amount shown falls at or under $23M (e.g., Solynta $23M on 2025-07-18, Revyve $28M on 2025-09-23). That means the highest disclosed figure is close to the next tier rather than an extreme gap.
The 12 entries also show a strong temporal middle: 7 of 12 rounds were dated between 2025-06-16 and 2025-11-13 (Scope Biosciences $1M on 2025-06-16 through Saia Agrobotics $12M on 2025-11-13). Sector-wise, biotech and agriculture/farming recur across multiple companies (e.g., New Dawn Bio in biotech with $2M on 2026-06-04; Saia Agrobotics in agriculture/AI/robotics; Scope Biosciences in agriculture/farming with $1M on 2025-06-16). Stages are also mixed, with multiple “Series Unknown” and “undisclosed” outcomes (2 “Series Unknown” and 2 “undisclosed” among 12), and the date window spans 2021-06-10 (FarmVent) to 2026-06-04 (New Dawn Bio).
Most recent rounds
12 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Wageningen set, and is it an outlier versus the rest?
The largest disclosed amount is Revyve at $28M (2025-09-23). The next-largest disclosed figures are Solynta at $23M (2025-07-18) and Micreos at $25M (2022-10-25), so the top is elevated but not separated by a large disclosed gap.
Do most rounds land in a narrow time window, or are they spread out across years?
They concentrate in 2025: 7 of 12 rounds are dated between 2025-06-16 (Scope Biosciences, $1M) and 2025-11-13 (Saia Agrobotics, $12M). Outside that window, the next cluster is smaller around 2022-10 (Greencovery $490K on 2022-10-20 and Micreos $25M on 2022-10-25).
How often do rounds show non-standard labels like “Series Unknown” or “undisclosed,” and how does that affect comparisons?
Among 12 rows, there are 2 “Series Unknown” entries (Hudson River Biotechnology and Solynta) and 2 “undisclosed” amount entries (Hudson River Biotechnology on 2024-04-12 and Micreos is labeled “Undisclosed” but still shows $25M). Because Hudson River Biotechnology’s amount is explicitly “undisclosed” (2024-04-12), it can’t be used in largest/smallest disclosed amount comparisons.
Which stages show up repeatedly, and does that pattern align with biotech/agri companies?
Seed appears more than once (Scope Biosciences $1M on 2025-06-16; Greencovery $490K on 2022-10-20). Series B also repeats (Revyve $28M on 2025-09-23; Rival Foods $12M on 2025-06-18), and those biotech/agriculture adjacency shows up across multiple rows such as New Dawn Bio (biotech, $2M on 2026-06-04) and Solynta (agriculture/farming, $23M on 2025-07-18).
Are any sectors or companies stand out as unusually large within their category?
Revyve’s $28M (2025-09-23, biotech) stands above the other disclosed biotech-sized rounds shown (e.g., New Dawn Bio $2M on 2026-06-04; Micreos $25M on 2022-10-25). In agriculture/farming-adjacent entries, Solynta’s $23M (2025-07-18) is far larger than Scope Biosciences at $1M (2025-06-16) and Greencovery at $490K (2022-10-20).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.